Selective delivery of T22-PE24-H6 to CXCR4(+) diffuse large B-cell lymphoma cells leads to wide therapeutic index in a disseminated mouse model

Background: Novel therapeutic strategies are urgently needed to reduce relapse rates and enhance survival in Diffuse Large B-Cell Lymphoma (DLBCL) patients. CXCR4-overexpressing cancer cells are good targets for therapy because of their association with dissemination and relapse in R-CHOP treated DL...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Theranostics
Autors principals: Falgàs, Aïda, Pallarès, Victor, Serna, Naroa, Sánchez-García, Laura, Sierra, Jorge, Gallardo, Alberto, Alba-Castellón, Lorena, Álamo, Patricia, Unzueta, Ugutz, Villaverde, Antonio, Vázquez, Esther, Mangues, Ramon, Casanova, Isolda
Format: Artigo
Idioma:Inglês
Publicat: Ivyspring International Publisher 2020
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7196303/
https://ncbi.nlm.nih.gov/pubmed/32373205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.43231
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars